REG - Primary Health Props - Director/PDMR Shareholding
Today 16:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250923:nRSW4936Aa&default-theme=true
RNS Number : 4936A Primary Health Properties PLC 23 September 2025
Primary Health Properties PLC
Director's & PDMR dealings
On 25 February 2025, the remuneration committee of Primary Health Properties
PLC (the "Company" or "PHP") approved the following awards of nil-cost options
under the Company's 2021 Long-term Incentive Plan ("LTIP") to Directors and
Persons Discharging Managerial Responsibilities ("PDMR's"). These awards,
deferred because the Company was subsequently in a prolonged closed period,
have now been made on 23 September 2025.
Director Number of shares under option
Mark Davies 969,643
Richard Howell 670,438
PDMR
David Austin 137,224
Toby Newman 120,421
The number of nil-cost options were calculated by reference to a price of
£0.8927, being the average of the closing middle market quotations for the
Company's ordinary shares on 17, 18 and 19 September 2025.
The nil-cost options will vest subject to the attainment of performance
conditions measured over three years to 31 December 2027. The remuneration
committee has the discretion to adjust the awards downwards at vesting for
malus reasons. Details of the operation of the LTIP are set out in the
Company's 2023 Report and Accounts.
Details of the transactions referenced above are included below in accordance
with the under Article 19 of the retained EU law version of the Market Abuse
Regulation (Regulation 596/2014).
1 Details of the person discharging managerial responsibilities/person closely
associated
(a) Name Mark Davies
2 Reason for notification
(a) Position/Status Chief Executive Officer
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date: and (iv) each
place where transactions have been conducted
(a) Description of the financial instrument, type of instrument and identification Ordinary shares of 12.5p
code
ISIN: GB00BYRJ5J14
(b) Nature of transaction Award of nil-cost options over the Company's ordinary shares
(c) Price(s) and volume(s) Price(s) Volume(s)
Nil cost 969,643
(d) Aggregated Information Single transaction: N/A
(e) Date of transaction 23 September 2025
(f) Place of transaction N/A
1 Details of the person discharging managerial responsibilities/person closely
associated
(a) Name Richard Howell
2 Reason for notification
(a) Position/Status Chief Financial Officer
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date: and (iv) each
place where transactions have been conducted
(a) Description of the financial instrument, type of instrument and identification Ordinary shares of 12.5p
code
ISIN: GB00BYRJ5J14
(b) Nature of transaction Award of nil-cost options over the Company's ordinary shares
(c) Price(s) and volume(s) Price(s) Volume(s)
Nil cost 670,438
(d) Aggregated Information Single transaction: N/A
(e) Date of transaction 23 September 2025
(f) Place of transaction N/A
1 Details of the person discharging managerial responsibility/person closely
associated
(a) Name David Austin
2 Reason for notification
(a) Position/Status PDMR
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date: and (iv) each
place where transactions have been conducted
(a) Description of the financial instrument, type of instrument and identification Ordinary shares of 12.5p
code
ISIN: GB00BYRJ5J14
(b) Nature of transaction Award of nil-cost options over the Company's ordinary shares
(c) Price(s) and volume(s) Price(s) Volume(s)
Nil cost 137,224
(d) Aggregated Information Single transaction: N/A
(e) Date of transaction 23 September 2025
(f) Place of transaction N/A
1 Details of the person discharging managerial responsibilities/person closely
associated
(a) Name Toby Newman
2 Reason for notification
(a) Position/Status Company Secretary & Chief Legal Officer
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date: and (iv) each
place where transactions have been conducted
(a) Description of the financial instrument, type of instrument and identification Ordinary shares of 12.5p
code
ISIN: GB00BYRJ5J14
(b) Nature of transaction Award of nil-cost options over the Company's ordinary shares
(c) Price(s) and volume(s) Price(s) Volume(s)
Nil cost 120,421
(d) Aggregated Information Single transaction: N/A
(e) Date of transaction 23 September 2025
(f) Place of transaction N/A
More information on Primary Health Properties PLC can be found on
www.phpgroup.co.uk
Further details:
Mark Davies via Burson Buchanan
Chief Executive Officer
Tel: +44 (0) 20 7466 5066
Richard Howell via Burson Buchanan
Chief Financial Officer Tel: +44 (0) 20 7466 5066
Stephanie Whitmore (Burson Buchanan)
Tel: +44 (0) 20 7466 5066
Legal Entity Identifier: 213800Y5CJHXOATK7X11
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBXGDCISDDGUXRecent news on Primary Health Properties
See all newsREG - Primary Health Props - Director/PDMR Shareholding
AnnouncementREG - Northern Trust Corp Assura plc Primary Health Props - Form 8.3 - Primary Health Properties PLC
AnnouncementREG - Primary Health Props - Notice of Interim Dividend
AnnouncementREG - Primary Health Props - Director/PDMR Shareholding
AnnouncementREG - Northern Trust Corp Assura plc Primary Health Props - Form 8.3 - Primary Health Properties PLC
Announcement